BMJ1d
Shared decision making in routine clinical care of patients with rheumatoid arthritis: an assessment of audio-recorded consultations
Objectives Although shared decision making (SDM) is advocated in rheumatoid arthritis (RA) treatment, it is largely unclear when, how and to what extent SDM is applied in routine clinical care of ...
BMJ2d
OP0042 NORMAL CREATINE KINASE IN IDIOPATHIC INFLAMMATORY MYOPATHIES-DISEASE CHARACTERISTICS AND OUTCOMES
2 University of Pittsburgh Medical Center, Division of Rheumatology and Clinical Immunology, Pittsburgh, Pennsylvania, United States of America 3 University of Pittsburgh Medical Center, Internal ...
BMJ2d
Low-ratio somatic NLRC4 mutation causes late-onset autoinflammatory disease
Objectives We aim to investigate the genetic basis of a case of late-onset autoinflammatory disease characterised by arthritis, recurrent fever and skin rashes. Methods We performed whole-exome/genome ...
BMJ3d
AB0191 SERUM BIOMARKER CHANGES IN JUVENILE IDIOPATHIC ARTHRITIS TRIAL USING BARICITINIB
3 Bristol Royal Hospital for Children and University of Bristol, School of Cellular and Molecular Medicine, Bristol, United Kingdom 4 Bristol Royal Hospital for Children and University of Bristol, ...
BMJ3d
Defining refractory rheumatoid arthritis
While biologic disease-modifying antirheumatic drugs (bDMARDs) have transformed outcomes of people with rheumatoid arthritis (RA), a proportion of patients are refractory to multiple bDMARDs.
BMJ4d
Safety and efficacy of vaccination against hepatitis B in patients with rheumatoid arthritis
Department of Rheumatology, Tel Aviv “Sourasky” Medical Centre and the “Sackler” Faculty of Medicine, University of Tel Aviv, Israel Correspondence to: Dr O Elkayam, Department of Rheumatology, Tel ...
BMJ4d
Oral steroid in the treatment of carpal tunnel syndrome
Dr S M Wong, Department of Medicine, Prince of Wales Hospital, 30–32 Ngan Shing Street, Shatin, New Territories, Hong Kong, Special Administrative Region China If you wish to reuse any or all of this ...
BMJ4d
Standardisation of myositis-specific antibodies: where are we today?
With interest we read the recent article by Espinosa-Ortega et al 1 comparing a line immunoassay (LIA) and immunoprecipitation (IP) for the detection of autoantibodies associated with idiopathic ...
BMJ5d
Gout: why is this curable disease so seldom cured?
3 Department of Rheumatology, University of Edinburgh, Centre for Molecular Medicine, Western General Hospital, Edinburgh, Scotland, UK 4 Department of Medicine, Rheumatology Section, Alicante ...
BMJ5d
Impact of pre-existing background therapy on placebo responses in randomised controlled clinical trials of rheumatoid arthritis
Objectives Various hypotheses exist for the explanation of placebo response rates in randomised controlled trials (RCTs) of patients with rheumatoid arthritis with IR to methotrexate (MTX). We ...
BMJ6d
Treatment of early oligoarticular psoriatic arthritis with apremilast: primary outcomes at week 16 from the FOREMOST randomised controlled trial
Objectives Oligoarticular psoriatic arthritis (PsA) is frequent but rarely studied. The objective was to assess the efficacy of apremilast in early oligoarticular PsA. Methods FOREMOST (NCT03747939) ...